We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Merck KGAA | TG:MRK | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.03% | 167.55 | 166.75 | 168.30 | 168.30 | 166.85 | 166.95 | 6,368 | 22:50:02 |
From May 2019 to May 2024
Belgian drug discovery company Galapagos NV (GLPG.BT) Wednesday said it has expanded its drug alliance with Merck & Co. Inc. (MRK) to include drugs that could treat atherosclerosis, the hardened arteries that cause heart attacks and strokes.
MAIN FACTS:
-Galapagos' alliance milestones will more than double to EUR400 million, plus royalties on worldwide sales.
-Galapagos already works with Merck on diabetes and obesity drug development.
Company Web site: www.glpg.com
Company Web site: www.merck.com
-By Brussels Bureau, Dow Jones Newswires; +322 741 1480;
1 Year Merck KGAA Chart |
1 Month Merck KGAA Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
